Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Regional Health PropertiesRHEP -7.27%47 3-Year EBITDA Growth Rate is 0.00% as of Mar. 2026. GuruFocus rates RHEP with a GF Score™ of 47/100 and a GF Value™ of $3.37 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 526 Healthcare Providers & Services companies, Regional Health Properties ranks worse than 190113.88% on this metric.
During the past 12 months, Regional Health Properties's average EBITDA Per Share Growth Rate was 280.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Regional Health Properties was 23.60% per year. The lowest was -64.20% per year. And the median was -14.65% per year.
Regional Health Properties (OTCPK:RHEP) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Regional Health Properties 3-Year EBITDA Growth Rate Related Terms
RHEP vs NIVF, XCRT, VLXC: 3-Year EBITDA Growth Rate Comparison
For the Medical Care Facilities subindustry, Regional Health Properties's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Regional Health Properties 3-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Regional Health Properties's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Regional Health Properties's 3-Year EBITDA Growth Rate falls into.
Regional Health Properties 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 0.00% mean?
Regional Health Properties (RHEP) has a 3-Year EBITDA Growth Rate of 0.00% as of Mar. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Regional Health Properties and its competitors. According to the industry distribution chart, Regional Health Properties ranks #999999 out of 526 companies in the Healthcare Providers & Services industry.
Is Regional Health Properties' 3-Year EBITDA Growth Rate too high?
Regional Health Properties' current 3-Year EBITDA Growth Rate is 0.00%. Based on the distribution chart, Regional Health Properties ranks #999999 out of 526 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Regional Health Properties has a GF Score™ of 47/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Regional Health Properties' 3-Year EBITDA Growth Rate compare to NIVF and XCRT?
According to the Healthcare Providers & Services industry distribution chart, Regional Health Properties ranks #999999 out of 526 companies for 3-Year EBITDA Growth Rate. This places Regional Health Properties in the lower half of its industry. The industry median 3-Year EBITDA Growth Rate is 10.20. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EBITDA Growth Rate among Healthcare Providers & Services companies is 10.20, based on 526 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Regional Health Properties and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EBITDA Growth Rate is 10.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Regional Health Properties's current 3-Year EBITDA Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Regional Health Properties stock overvalued right now?
Based on GuruFocus' analysis, Regional Health Properties (RHEP) is currently considered Possible Value Trap. The stock's GF Value™ is $3.37, compared to a current price of $1.02 — trading 69.7% below its estimated fair value. The current 3-Year EBITDA Growth Rate is 0.00%. Regional Health Properties' overall GF Score™ is 47/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Regional Health Properties (RHEP), the current 3-Year EBITDA Growth Rate is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Regional Health Properties (RHEP) Overvalued in 2026?
Based on GuruFocus' analysis, Regional Health Properties stock appears to be undervalued.
The current stock price of $1.02 is trading 69.7% below its estimated GF Value™ of $3.37.
GuruFocus considers Regional Health Properties to be Possible Value Trap.
Key valuation signals for RHEP:
3-Year EBITDA Growth Rate: 0.00%
GF Value™: $3.37 vs. price of $1.02 (69.7% below fair value)
No single metric tells the full story. See the RHEP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Regional Health Properties Inc is a healthcare company that owns, operates and invests in healthcare real estate and operating businesses focused on long-term care, senior housing and pharmacy services. Through its subsidiaries, the Company owns and operates skilled nursing and senior housing communities that provide a range of healthcare and residential services, including sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative therapy, memory care, Alzheimer's and dementia care and senior living services. It has two reportable segments real estate segment, Pharmacy Services and the healthcare services segment. It derives the majority of its revenue from the healthcare services segment.
47GF Score
Get the complete analysis for RHEP
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RHEP has been successfully added to your 
